Promises
2 promises
Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Hindunilvr Ltd — Q4 FY24
HUL reported a resilient Q4 FY24 with underlying volume growth of 2% and sales growth of 1%, amid gradual demand recovery.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
HUL reported a resilient Q4 FY24 with underlying volume growth of 2% and sales growth of 1%, amid gradual demand recovery. EBITDA margin contracted 30bps YoY to 23.4%, as gross margin expansion of 350bps was reinvested into A&P (up 200bps to 10.8%) and capabilities. Beauty & Wellbeing grew mid-single digit, while Personal Care declined 10% due to mass skin cleansing weakness. Management expects near-term pricing to remain negative, turning positive by H2 FY25, and aims to maintain EBITDA margins at current levels. Key risk: slower-than-expected rural recovery and competitive intensity in mass segments.
HUL ने चौथी तिमाही में 2% वॉल्यूम बढ़ोतरी और 1% बिक्री बढ़ोतरी दर्ज की। मुनाफा मार्जिन 23.4% रहा, जो पिछले साल से थोड़ा कम है। कंपनी ने कच्चे माल की बचत से हुए फायदे को विज्ञापन और नई क्षमताओं पर खर्च किया। ब्यूटी प्रोडक्ट्स की बिक्री अच्छी रही, लेकिन साबुन जैसे सस्ते उत्पाद कम बिके। आने वाले महीनों में कीमतें घट सकती हैं, लेकिन साल के दूसरे हिस्से में बढ़ने की उम्मीद है। कंपनी मुनाफा मार्जिन मौजूदा स्तर पर रखना चाहती है। मुख्य चुनौती: गांवों में मांग धीमी रहना और सस्ते उत्पादों में कड़ी प्रतिस्पर्धा।
Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Slow rural recovery
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Underlying Volume Growth (UVG)
2%
Flat YoY
UVG remained at 2% YoY, with 75% of business growing volumes and 50% growing mid-to-high single digit.
A&P Spend as % of Sales
10.8%
+200bps YoY
A&P investments increased by ~INR 300 Cr YoY, maintaining share of voice ahead of share of market.
Gross Margin
51.3%
+350bps YoY
Gross margin expanded 350bps YoY driven by benign commodities, mix improvement, and productivity gains.
Beauty & Wellbeing USG
Mid-single-digit
Volume-driven
Beauty & Wellbeing delivered mid-single-digit USG led by hair care (high single-digit) and premium skin (double-digit).
What Changed vs Last Quarter
NEW
Maintain EBITDA margin at current levels in near term
Management expects to keep EBITDA margin around 23.4% in the short term, with modest improvement over medium to long term.
NEW
Pricing to turn positive low single-digit by H2 FY25
If commodity prices remain stable, price growth is expected to plateau in mid-term and become positive low single-digit by end of FY25.
NEW
Volume-led competitive growth focus
Focus remains on driving competitive volume-led growth across the business, with gradual demand recovery expected.
NEW
Skin cleansing improvement over mid-term
Actions underway to address mass skin cleansing performance, with improvement expected over the next few quarters.
DROPPED
Marginal negative price growth expected in Q4 FY24
If commodity prices remain at current levels, management expects underlying price growth to be marginally negative in the March quarter.
DROPPED
EBITDA margins to remain in healthy 23-24% range
Management aims to maintain EBITDA margins at current healthy levels, with a focus on gross margin improvement back to pre-COVID levels.
DROPPED
Business Winning metric to dip below 60% then recover
The MAT business winning metric is expected to dip below 60% for a couple of quarters before recovering above 60% in the second half of calendar 2024.
DROPPED
Continued step-up in A&P and capability investments
Management plans to further increase investments behind brands, innovation, and digital capabilities, funded by gross margin expansion.
NEW RISK
Slow rural recovery
Rural demand remains weak due to cumulative inflation and weak monsoon; recovery is gradual and may be impacted by rising telecom costs.
NEW RISK
Competitive intensity in mass segments
Mass skin cleansing and fabric wash liquids face increased competition from regional and global players, pressuring volumes and pricing.
NEW RISK
Commodity price volatility
Rising crude or CPO prices could reverse gross margin gains and require price increases, impacting volume growth.
NEW RISK
GSK consignment agreement impact
The end of the GSK distribution agreement will impact EBITDA by ~60bps for the next four quarters, pressuring margins.
RISK GONE
Rural demand recovery slower than expected
Rural consumer sentiment remains subdued due to lower agriculture yields and income uncertainty; recovery pace depends on winter crop yields and government spending.
RISK GONE
Resurgence of regional and small players
Benign commodity environment has led to increased competition from regional players, particularly in detergent bars and tea, impacting market share momentum.
RISK GONE
GSK distribution income loss from Q1 FY25
The termination of the GSK distribution agreement will result in the loss of approximately INR 300 crore annual income, impacting margins from next quarter.
RISK GONE
Tea downgrading persists despite market share gains
Consumers continue to downgrade from branded tea to loose tea due to price differentials, pressuring F&R volumes despite value and volume market share gains.
🤫 Topics management stopped discussing
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Benign commodity environment has led to increased competition from regional players, particularly in detergent bars and tea, impacting market share momentum.
Mentioned in Q2 FY24, Q3 FY24
Management aims to maintain EBITDA margins at current healthy levels, with a focus on gross margin improvement back to pre-COVID levels.
Mentioned in Q1 FY24, Q2 FY24
Management expects price growth to turn marginally negative in the near term if current commodity prices hold.
Fast read
Guidance and risk preview
Management expects to keep EBITDA margin around 23.4% in the short term, with modest improvement over medium to long term.
Rural demand remains weak due to cumulative inflation and weak monsoon; recovery is gradual and may be impacted by rising telecom costs.
View Risks →